BioNTech to Present at 36th Annual J.P. Morgan Healthcare Conference

Mainz, Germany, December 21, 2017 – BioNTech AG, a fully-integrated biotechnology company pioneering individualized cancer immunotherapy, today announced that Sean Marett, COO of BioNTech, will be presenting at the 36th Annual J.P. Morgan Healthcare Conference that is being held in San Francisco, CA from January 8-11, 2018. The Company’s presentation is scheduled for Tuesday, January 9 at 9:00 AM Pacific Standard Time.

Mr. Marett will provide an overview of the Company´s strategy as well as an update on its development programs, including  its expanding clinical pipeline, in-house manufacturing capabilities, and a summary of human clinical data recently published in Nature publication on its neo-epitope based individualized mRNA cancer immunotherapeutic.

For meeting requests or further information, please contact:                

General Inqriries
Regina Jehle
BioNTech AG
Phone: +49 6131 9084 1273
Email: Regina.Jehle@biontech.de

Investors
ICR, Inc.
Stephanie Carrington
Phone: +1 646-277-1282
Email: Stephanie.Carrington@icrinc.com

Media
ICR, Inc.
James Heins
Phone: +1 203-682-8251
Email: James.Heins@icrinc.com

*** Announcement in English – PDF ***